Instructions for Cifran OD (ciprofloxacin) pills
English Product Name
Cifran OD
Release Form
tab. extended action, covered by film, 500 mg: 5 or 10 pcs.
tab. prolonged action, covered with film, 1000 mg: 5 or 10 pcs.
Description Cifran OD
Long-acting tablets, covered with a film coating from white to almost white, oval, on one side printed with food ink "Cifran OD 1000MG"; the view on the fracture - pressed mass from white to almost white.
1 tab
ciprofloxacin 1000 mg
Auxiliary substances: sodium alginate (Keltone LVCR), hypromellose, sodium hydrocarbonate, crospovidone (CLM), magnesium stearate, silicon colloidal dioxide (200), talc.
The composition of the film shell: opadrai white 31V58910*, talc, hypromellose, purified water**, ink for inscription black*** (Opacod-S-1-17823 black).
5 pcs - blisters (1) - cardboard packs.
5 pcs - blisters (2) - cardboard packs.
* the composition of fallen white 31B58910: hypromellose, lactose, titanium dioxide, macrogol 400;
** evaporates during the production process;
*** the composition includes: shellac 45% (20% esterified) in ethanol, isopropanol, n-butanol, propylene glycol, ammonia aquatic 28%, iron oxide black dye.
ATX codes Cifran OD
J01MA02 Ciprofloxacin
Clinical and pharmacological groups / Group affiliation
Fluoroquinolone group antibacterial
Active ingredient
ciprofloxacin
Pharmacotherapeutic group Cifran OD
Antimicrobial agent - fluoroquinolone
Retention conditions
The drug should be stored in a dry, inaccessible place for children at a temperature not exceeding 25° C.
Expiration date
The expiration date is two years. Do not apply after expiry date.
Pharmacological effect Cifran OD
fluoroquinolones are caused by the ability to suppress the activity of a bacterial enzyme called topoisomerase II (DNA gyrase). Topoisomerase II is required for normal DNA replication in bacteria. The absence of this enzyme leads to uncontrolled replication of the damaged DNA and thus to defective synthesis of normal proteins within the bacterial cell.
The antimicrobial spectrum of ciprofloxacin is broad and covers many gram-negative and gram-positive bacteria, as established by in vitro experimental studies as well as clinical observations. Ciprofloxacin affects both active and dormant reproducing organisms. This drug is active against most strains of the following microorganisms.
Testimony Cifran OD
The preparation Tsifran® OD is designed to treat a variety of infectious and inflammatory diseases caused by sensitive microorganisms. Here is a list of such diseases:
- Acute sinusitis;
Lower respiratory infections and inflammations, including pneumonia, acute exacerbation of chronic bronchitis and infectious complications of cystic fibrosis;
- Pyelonephritis and cystitis, including complicated forms;
- Chronic bacterial prostatitis;
- Gonorrhea;
- Intra-abdominal infections such as peritonitis, intra-abdominal abscesses, cholangitis, cholecystitis and gallbladder empyema. Ciphran® OD is used in combination with metronidazole;
- Skin infections;
- Bone and joint infections, including acute and chronic osteomyelitis;
- Infectious diarrhea, including traveler's diarrhea;
- Typhoid fever;
- Anthrax.
Method of use, course and dosage
The drug Ciphran® OD is administered by mouth. The pills should be taken after eating whole meals and sipping plenty of water. It is not recommended to crack, chew or otherwise destroy the tablets. Continued use of ®, at least 2 days after symptom resolution is complete.
Nosology (ICD codes)
A01
Typhus and paratyphus
A09
Other gastroenteritis and colitis of infectious and unspecified origin
A22
Anthrax
A54
Gonococcal infection
E84.8
Cystic fibrosis with other manifestations
J01
Acute sinusitis
J15
Bacterial pneumonia, not elsewhere classified
J20
Acute bronchitis
J42
Chronic bronchitis, unspecified
K65.0
Acute peritonitis (including abscess)
K81.0
Acute cholecystitis
K81.1
Chronic cholecystitis
K83.0
Cholangitis
L01
Impetigo
L02
Skin abscess, furuncle and carbuncle
L03
Cellulitis
L08.0
Pyoderma
M00
Pyogenic arthritis
M86
Osteomyelitis
N10
Acute tubuloinsterstitial nephritis (acute pyelonephritis)
N11
Chronic tubulointerstitial nephritis (chronic pyelonephritis)
N30
Cystitis
N41
Inflammatory diseases of prostate
T79.3
Posttraumatic wound infection, not elsewhere classified
